Literature DB >> 26107044

Diagnostic Accuracy of the Slump Test for Identifying Neuropathic Pain in the Lower Limb.

Lawrence M Urban1, Brian J MacNeil.   

Abstract

STUDY
DESIGN: Diagnostic accuracy study with nonconsecutive enrollment.
OBJECTIVES: To assess the diagnostic accuracy of the slump test for neuropathic pain (NeP) in those with low to moderate levels of chronic low back pain (LBP), and to determine whether accuracy of the slump test improves by adding anatomical or qualitative pain descriptors.
BACKGROUND: Neuropathic pain has been linked with poor outcomes, likely due to inadequate diagnosis, which precludes treatment specific for NeP. Current diagnostic approaches are time consuming or lack accuracy.
METHODS: A convenience sample of 21 individuals with LBP, with or without radiating leg pain, was recruited. A standardized neurosensory examination was used to determine the reference diagnosis for NeP. Afterward, the slump test was administered to all participants. Reports of pain location and quality produced during the slump test were recorded.
RESULTS: The neurosensory examination designated 11 of the 21 participants with LBP/sciatica as having NeP. The slump test displayed high sensitivity (0.91), moderate specificity (0.70), a positive likelihood ratio of 3.03, and a negative likelihood ratio of 0.13. Adding the criterion of pain below the knee significantly increased specificity to 1.00 (positive likelihood ratio = 11.9). Pain-quality descriptors did not improve diagnostic accuracy.
CONCLUSION: The slump test was highly sensitive in identifying NeP within the study sample. Adding a pain-location criterion improved specificity. Combining the diagnostic outcomes was very effective in identifying all those without NeP and half of those with NeP. Limitations arising from the small and narrow spectrum of participants with LBP/sciatica sampled within the study prevent application of the findings to a wider population. LEVEL OF EVIDENCE: Diagnosis, level 4-.

Entities:  

Keywords:  neurodynamic testing; sensitivity; specificity

Mesh:

Year:  2015        PMID: 26107044     DOI: 10.2519/jospt.2015.5414

Source DB:  PubMed          Journal:  J Orthop Sports Phys Ther        ISSN: 0190-6011            Impact factor:   4.751


  5 in total

1.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

2.  The potential role of sciatic nerve stiffness in the limitation of maximal ankle range of motion.

Authors:  Ricardo J Andrade; Sandro R Freitas; François Hug; Guillaume Le Sant; Lilian Lacourpaille; Raphäel Gross; Peter McNair; Antoine Nordez
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

3.  Diagnostic utility of patient history, clinical examination and screening tool data to identify neuropathic pain in low back-related leg pain: protocol for a systematic review.

Authors:  Jai Mistry; Nicola R Heneghan; Timothy Noblet; Deborah Falla; Alison Rushton
Journal:  BMJ Open       Date:  2019-11-24       Impact factor: 2.692

4.  Diagnostic utility of patient history, clinical examination and screening tool data to identify neuropathic pain in low back related leg pain: a systematic review and narrative synthesis.

Authors:  Jai Mistry; Nicola R Heneghan; Tim Noblet; Deborah Falla; Alison Rushton
Journal:  BMC Musculoskelet Disord       Date:  2020-08-10       Impact factor: 2.362

5.  Use of Neurodynamic or Orthopedic Tension Tests for the Diagnosis of Lumbar and Lumbosacral Radiculopathies: Study of the Diagnostic Validity.

Authors:  Francisco Javier González Espinosa de Los Monteros; Gloria Gonzalez-Medina; Elisa Maria Garrido Ardila; Juan Rodríguez Mansilla; José Paz Expósito; Petronila Oliva Ruiz
Journal:  Int J Environ Res Public Health       Date:  2020-09-26       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.